September 7, 2017
Stories this photo appears in:
New Investor’s Top Client Includes Facebook Founder
ChromaDex Corp. in Irvine will raise $23 million via the private placement on Nov. 17 of 5.6 million common shares at $4.10 apiece, which follows a $25 million investment led by Hong Kong billionaire Li Ka-Shing that concluded in August.
Irvine-based ChromaDex Corp. reported $6.1 million in sales for its most recent quarter, up 55% year-over-year, and a net loss of $3.2 million, about 30% more than the same period last year.
Irvine-based ChromaDex Corp. will sell more than 5.6 million shares of its common stock at a purchase price of $4.10 per share, or about $23 million.
HEALTHCARE: Focus on own supplement brand
An obsession with eternal youth is in vogue, and not limited to Americans; the global antiaging market is projected to grow from $250 billion last year to $331.4 billion in 2021, according to a report by Orbis Research in Dallas.